user

The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs

被引：41
|
作者：
Bernstein, David I. [1 ]
Farley, Nicholas [1 ]
Bravo, Fernando J. [1 ]
Earwood, Julie [1 ]
McNeal, Monica [1 ]
Fairman, Jeff [2 ]
Cardin, Rhonda [1 ]
机构：
[1] Univ Cincinnati, Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA
[2] Juvaris BioTherapeut Inc, Burlingame, CA USA
来源：
VACCINE | 2010年 / 28卷 / 21期
关键词：
HSV vaccine; Adjuvant; Genital herpes; Guinea pig; CLDC; RECURRENT GENITAL HERPES; VIRUS TYPE-2; DNA COMPLEXES; IMMUNOTHERAPY; TRANSMISSION; IMMUNIZATION; PREVENTION; INFECTION; DELIVERY; TRIAL;
D O I：
10.1016/j.vaccine.2009.10.025
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Herpes simplex virus (HSV) infections are common but there is no vaccine available. We evaluated cationic liposorne-DNA complexes (CLDC) as an adjuvant for an HSV gD2 vaccine and compared it to an MPL/Alum adjuvant in a guinea pig model of genital herpes. The addition of CLDC to the gD2 vaccine significantly decreased acute and recurrent disease and most importantly the number of days with recurrent virus shedding compared to gD2 alone. Reductions in these outcomes were also detected when gD2 + CLDC was compared to gD2 + MPL/Alum. When the vaccine and adjuvants were evaluated as therapeutic vaccines, they were ineffective. CLDC enhanced protection compared to MPL/Alum and is the first vaccine to reduce recurrent virus shedding, a key to decreasing the spread of HSV-2. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3748 / 3753
页数：6
相关论文
共 50 条
  • [31] Expression of the glycoprotein D of herpes simplex virus type-2 in insect cells
    Fotouhi, F.
    Roustaee, M.
    Soleimanjahi, H.
    Haqshenas, G. R.
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (10) : S101 - S101
  • [32] Detection of type 2 herpes simplex virus in cells of spermatogenic epithelium in infected testes of guinea pigs
    Gribencha, S. V.
    Bragina, E. E.
    Abdumalikov, R. A.
    Bocharova, E. N.
    Kurilo, L. F.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 144 (01) : 73 - 76
  • [33] Analysis of herpes simplex virus type 1 glycoprotein D nucleotide sequence in human herpes simplex encephalitis
    Rozenberg, F
    Lebon, P
    JOURNAL OF NEUROVIROLOGY, 1996, 2 (04) : 289 - 295
  • [34] Detection of type 2 herpes simplex virus in cells of spermatogenic epithelium in infected testes of guinea pigs
    S. V. Gribencha
    E. E. Bragina
    R. A. Abdumalikov
    E. N. Bocharova
    L. F. Kurilo
    Bulletin of Experimental Biology and Medicine, 2007, 144 : 73 - 76
  • [35] DNA vaccine expressing herpes simplex virus 1 glycoprotein C and D protects mice against herpes simplex keratitis
    Li-Li Dong
    Ru Tang
    Yu-Jia Zhai
    Tejsu Malla
    Kai Hu
    International Journal of Ophthalmology, 2017, 10 (11) : 1633 - 1639
  • [36] DNA vaccine expressing herpes simplex virus 1 glycoprotein C and D protects mice against herpes simplex keratitis
    Dong, Li-Li
    Tang, Ru
    Zhai, Yu-Jia
    Malla, Tejsu
    Hu, Kai
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (11) : 1633 - 1639
  • [37] An Adjuvanted Herpes Simplex Virus 2 Subunit Vaccine Elicits a T Cell Response in Mice and Is an Effective Therapeutic Vaccine in Guinea Pigs
    Skoberne, Mojca
    Cardin, Rhonda
    Lee, Alexander
    Kazimirova, Ana
    Zielinski, Veronica
    Garvie, Danielle
    Lundberg, Amy
    Larson, Shane
    Bravo, Fernando J.
    Bernstein, David I.
    Flechtner, Jessica B.
    Long, Deborah
    JOURNAL OF VIROLOGY, 2013, 87 (07) : 3930 - 3942
  • [38] IMMUNOTHERAPY OF GENITAL HERPES WITH A RECOMBINANT HERPES-SIMPLEX VIRUS TYPE-2 GLYCOPROTEIN D (GD2) VACCINE - A PLACEBO-CONTROLLED TRIAL
    MEIER, J
    COREY, L
    BURKE, RL
    SAVARESE, B
    BARNUM, G
    KOST, R
    ADAIR, S
    DEKKER, C
    STRAUS, SE
    CLINICAL RESEARCH, 1993, 41 (02): : A199 - A199
  • [39] Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs
    Quenelle, Debra C.
    Collins, Deborah J.
    Rice, Terri L.
    Prichard, Mark N.
    Marciani, Dante J.
    Kern, Earl R.
    ANTIVIRAL RESEARCH, 2008, 80 (02) : 223 - 224
  • [40] Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
    Egan, Kevin
    Hook, Lauren M.
    Naughton, Alexis
    Friedman, Harvey M.
    Awasthi, Sita
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (09) : 2109 - 2113
12345